ONWARD Medical’s AGM Resolutions Approved

Eindhoven, the Netherlands — June 11, 2025 — ONWARD Medical N.V., a neurotechnology firm listed on Euronext and OTCQX, announced the approval of all resolutions during its Annual General Meeting of Shareholders (AGM) held in Amsterdam. The meeting, conducted at 4:00 PM CET, confirmed shareholder agreement on proposed decisions, underscoring support for the company’s strategic direction.

ONWARD Medical, noted for its pioneering work in neurotechnology, continues to develop therapies aiming to restore movement and independence for those with spinal cord injuries. The company’s notable ARC Therapy and ARC-EX System have received significant recognition, with regulatory clearances bolstering investor confidence.

Details of the AGM’s approved resolutions are available on the company’s Investor Relations website, offering transparency and investor engagement.